Androcur Depot 300 mg Injection
PDF Leaflet Revision Date: 14/12/2021
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of drive in sexual deviations in males; Antiandrogen treatment in inoperable carcinoma of the prostate.
Dosage (summary)
1 ampoule (300 mg) IM every 10-21 days; 300 mg weekly without orchidectomy.
Special Populations
- Paediatric population
- Hepatic impairment
- Geriatric patients
- Renal impairment
Pregnancy & Breastfeeding
Not indicated for women; safety in pregnancy not established.
Key Drug Interactions
- CYP3A4 inhibitors (e.g., ketoconazole)
- CYP3A4 inducers (e.g., rifampicin)
Contraindications
- Liver diseases
- Meningioma
- Thromboembolic processes
- Severe diabetes with vascular changes
Common side effects
- Decreased libido
- Erectile dysfunction
- Hepatic toxicity
- Thromboembolic events
Counselling Points
- Monitor liver function regularly
- Avoid alcohol during treatment
- May impair ability to concentrate
Serious warnings
- Hepatic toxicity
- Risk of meningioma
- Thromboembolic events
Important Disclaimer
The Androcur Depot 300 mg Injection professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
